Concepedia

Roberto D. Liu

RD

Statistics

Publications

3

Citations

65

H-Index

3

Active since

2013

Affiliations

The Netherlands Cancer Institute(Current)

Erasmus University Rotterdam

University Medical Center Groningen

Amsterdam UMC Location University of Amsterdam

Amsterdam University Medical Centers

Roberto D. Liu is an author at The Netherlands Cancer Institute specializing in medicine, immunotherapy, and relapsed disease.

Publications per year

2013–2019

3

Publications

3

Combining Brentuximab Vedotin with DHAP as Salvage Treatment in Relapsed/Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE study

Anton Hagenbeek, Josée M. Zijlstra, Wouter J. Plattel et al. · Blood · 2018 · 28 citations

, , +11

Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: A multicenter phase 2 study

Arnon P. Kater, Marjolein Spiering, Roberto D. Liu et al. · Leukemia Research · 2013 · 25 citations

, , +12

Ixazomib, Rituximab and Dexamethasone (IRD) in Patients with Relapsed or Progressive Waldenstrom's Macroblobulinemia: Results of the Prospective Phase I/II HOVON 124/Ecwm-R2 Trial

Marie José Kersten, Monique C. Minnema, Josephine M. I. Vos et al. · Blood · 2019 · 12 citations

, , +9

1–3 of 3